|
Real-time Estimate
Cboe BZX
09:55:26 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 26.10 USD | -0.55% |
|
+0.45% | +15.22% |
| 06:07am | Ultragenyx Pharmaceutical Inc. - Special Call | |
| 08-19 | Ultragenyx Pharmaceutical Receives Accelerated US FDA Approval for Genglycos | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
RARE 26.79 $
+2.10%
22.83M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| RARE | 26.79USD | +2.10% | 22.83M $ | |
CBOE
| RARE | 25.93USD | -1.18% | 676K $ | |
|
Tradegate
| UP0 | 22.48EUR | +0.04% | 57.77K € | |
|
Börse Stuttgart
| UP0 | 23.17EUR | +3.44% | 20.85K € | |
|
Boerse Muenchen
| UP0 | 22.45EUR | -1.36% | 8.1K € | |
|
London S.E.
| 0LIF | 24.57USD | -31.52% | 368.55 $ | |
|
Mexican S.E.
| RARE * | 450.00MXN | -60.89% | 6.3K $ | |
|
Deutsche Boerse AG
| UP0 | 25.45EUR | +15.16% | 0 € | |
|
Berne S.E.
| UP0 | 21.20CHF | +3.29% | 0 CHF | |
Sao Paulo
| R2AR34 | 14.40BRL | +5.73% | 1.44K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 28.62 | 35.87 | 36.38 |
| Spread/Res. | -7.41% | -26.12% | -27.16% |
| Spread/Supp. | +6.38% | +43.24% | +36.74% |
| Support | 24.91 | 18.5 | 19.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RARE Stock
- Charts Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
